Key Account Manager, South and South Wales

Come and Save Lives with Us!

SERB is a fast-growing specialty pharmaceutical company that equips healthcare providers worldwide with life‑saving medicines for patients facing rare conditions and emergencies.

For over 30 years we have consistently provided emergency medicines, medical countermeasures, and the world’s leading portfolio of antidotes.

Today SERB has over 500 employees in 18 countries and group revenue in excess of €400m. With a strong presence in the US, Europe, and the Middle East, along with a global network of trusted distribution partners, we make a broad range of essential medicines available in over 100 countries.

Having the right culture is as important to us as having the right portfolio. We are guided by our four values:

• We make patients our priority
• We act with accountability and integrity
• We work together as one team
• We look for better ways forward

By expanding our reach through selective acquisitions and entering new markets, we’re not just supplying medicine; we’re improving the standard of care for more patients around the world.

To achieve sales budget and business objectives by implementing strategies and tactics with specialist customers in line with commercial plans to contribute to the overall UK budget.

To promote the Group’s diverse product portfolio to deliver the Key Strategic Objectives, maintain key accounts and develop partnerships with Integrated Care Boards, Medicines optimisation Teams, critical NHS Trusts, Health Boards and Healthcare Professionals (HCPs) and payors.

To identify and establish strong, sustainable relationships with key stakeholders across Primary and Secondary Care (clinical and non-clinical) and leverage customer insights to create strategies that will ensure the maintenance and growth of the Group’s portfolio in the UK and to ensure commercial objectives are met as per plan.

Drive the development of commercially positive formulary, guideline and protocol inclusions for promoted brands in target accounts across both primary and secondary care incorporating trust and APC formularies where appropriate. This includes securing of reimbursement (where appropriate), permission to prescribe, as well as the subsequent implementation and business pull-through. Deliver other business‑critical market access projects e.g., service redesign/shared care guidelines.

Generate clinical demand for products and promote and sell product(s) (prescribing, non‑prescribing and commercial).

Accountable for achievement of the territory sales target. The Regional and National Sales Plan is delivered via organic growth and increase through new channels/customer accounts.

Ensure adherence and compliance to all relevant Corporate, MHRA and ABPI guidelines.

The individual will be required to travel extensively within the regions 4‑5 days a week and stay away from home when required. There is a minimum expectation that 90% of time is spent in field seeing customers. There may be some overseas travel required.

• Ensure regular and frequent customer contact through one to one, group meetings, speaker meetings and symposia.
• Identify and develop Key Opinion Leader’s to drive strategy e.g.: formulary approval, protocol change, product uptake.
• Ensure tenders for the Group’s portfolio are completed and submitted at Hospital and Regional level, once authorised by the Line Manager.
• Ensure that tenders that are up for renewal are carefully evaluated for any adverse financial impact on current terms with a proposal for mitigating actions.
• To achieve commercially positive formulary listings, guidelines and protocol changes within targeted key accounts.
• Work collaboratively with the wider Market Access and Marketing teams to ensure that engagement with KOLs is timely and at the right level to provide appropriate support and advocacy of the Group’s product portfolio.
• Complete Company administrative requirements with agreed timelines.

• Ensure all identified key accounts have a named contact for each product purchased (Clinical and non‑clinical).
• Assess and develop pricing…